In its new guideline, the AGA recommends infliximab, adalimumab, ustekinumab, risankizumab, mirikizumab, guselkumab or ...

T reatment of moderate-to-severe Crohn's disease should prioritize early use of higher-efficacy advanced therapies rather ...

People with Crohn's disease usually experience intense abdominal pain and diarrhea. The pain can be anywhere in the ...

New guidelines recommend doctors tackle Crohn's disease head-on, calling for the use of cutting-edge drugs as early as ...

The American Gastroenterological Association's new guideline uses cutting-edge network meta-analyses to recommend prescribing ...

Scientists at the University of Oxford, have identified how rare populations of abnormal cells drive the formation and ...

The American Gastroenterological Association has released updated guidelines for treating moderate-to-severe Crohn’s disease, outlining 16 evidence-based recommendations that prioritize advanced ...

Artificial intelligence helps UCSD scientists discover a biological process connected to the bowel disease, potentially ...

Oxford researchers discover rogue fibroblasts that erode tissue and stabilize tunnels in Crohn’s fistulas, revealing targets ...

ATHENS, Ga. — Former University of Georgia head football coach Mark Richt and his family are fighting a battle against two ...

STENOVA trial achieves primary endpoint in 103 study participants after 12 weeks of treatment -- -- Pharmacokinetic results confirm ...

Macrophages can alternate between two states: an inflammatory state for fighting infection and a non-inflammatory state for ...